CH323174A - Process for preparing a steroid carrying an aldehyde function in position 17 - Google Patents
Process for preparing a steroid carrying an aldehyde function in position 17Info
- Publication number
- CH323174A CH323174A CH323174DA CH323174A CH 323174 A CH323174 A CH 323174A CH 323174D A CH323174D A CH 323174DA CH 323174 A CH323174 A CH 323174A
- Authority
- CH
- Switzerland
- Prior art keywords
- steroid
- ether
- solution
- aldehyde function
- preparing
- Prior art date
Links
- 150000003431 steroids Chemical class 0.000 title claims description 7
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 title claims 2
- 238000004519 manufacturing process Methods 0.000 title description 2
- 238000000034 method Methods 0.000 claims description 6
- 150000001875 compounds Chemical class 0.000 claims description 4
- -1 nitrogenous organic base Chemical class 0.000 claims description 3
- 238000002360 preparation method Methods 0.000 claims description 3
- 239000002635 aromatic organic solvent Substances 0.000 claims description 2
- 150000001734 carboxylic acid salts Chemical class 0.000 claims description 2
- QJGQUHMNIGDVPM-UHFFFAOYSA-N nitrogen group Chemical group [N] QJGQUHMNIGDVPM-UHFFFAOYSA-N 0.000 claims 1
- RAIYODFGMLZUDF-UHFFFAOYSA-N piperidin-1-ium;acetate Chemical group CC([O-])=O.C1CC[NH2+]CC1 RAIYODFGMLZUDF-UHFFFAOYSA-N 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 23
- 239000000243 solution Substances 0.000 description 10
- 239000000047 product Substances 0.000 description 7
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 239000000203 mixture Substances 0.000 description 5
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000001299 aldehydes Chemical group 0.000 description 3
- 238000001704 evaporation Methods 0.000 description 3
- 230000008020 evaporation Effects 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 2
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 2
- ZNZYKNKBJPZETN-WELNAUFTSA-N Dialdehyde 11678 Chemical compound N1C2=CC=CC=C2C2=C1[C@H](C[C@H](/C(=C/O)C(=O)OC)[C@@H](C=C)C=O)NCC2 ZNZYKNKBJPZETN-WELNAUFTSA-N 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 2
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical compound C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000001257 hydrogen Substances 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 230000007935 neutral effect Effects 0.000 description 2
- 239000012299 nitrogen atmosphere Substances 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 238000001953 recrystallisation Methods 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229960000583 acetic acid Drugs 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000010575 fractional recrystallization Methods 0.000 description 1
- 239000012362 glacial acetic acid Substances 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000012280 lithium aluminium hydride Substances 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- PESSIQDIMKDTSP-UHFFFAOYSA-N periodic acid;dihydrate Chemical compound O.O.OI(=O)(=O)=O PESSIQDIMKDTSP-UHFFFAOYSA-N 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- 238000007363 ring formation reaction Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 229910052938 sodium sulfate Inorganic materials 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J3/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by one carbon atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
Description
Procédé de préparation d'un stéroïde portant en position 17 une fonction aldéhyde Le brevet suisse No 298506 décrit un pro cédé de préparation de O9(il),is-bisdéhydro-21- norprogestérone de formule
EMI0001.0005
à partir d'un composé de formule
EMI0001.0006
La présente invention concerne un procédé de préparation d'un stéroïde portant en posi tion 17 une fonction aldéhyde ;
ce procédé est caractérisé en ce qu'on chauffe une solution d'un composé de formule
EMI0001.0009
au sein d'un solvant organique aromatique, en présence d'un sel d'acide carboxylique d'une base organique azotée et en ce qu'on recueille le stéroïde ainsi formé, de formule
EMI0001.0011
Ce stéroïde est utile comme intermédiaire intéressant dans la synthèse de la progestérone. L'exemple suivant illustre l'invention.
Le produit de départ est préparé comme suit, en trois étapes a) On alcalinise une suspension de 23 mg de noir de palladium dans 20 cc de méthanol absolu par addition de deux gouttes d'une solution aqueuse à 10 % d'hydroxyde de sodium, on ajoute 133,4 mg du cétal acéto- nique du 3-céto-16,17-dihydroxy-A4,9(ii)
-D- homo-androstadiène [préparé comme décrit dans le brevet No 319580] et on secoue le mélange sous atmosphère d'hydrogène jusqu'à cessation de l'absorption de l'hydrogène. On ajoute comme adjuvant de filtration du produit marque Celite , on filtre la solution et on évapore le filtrat à siccité. On chromatographie le produit sur 5 g d'alumine neutre et on soumet à la recristallisation fractionnée l'éluat benzénique au sein d'éther isopropylique : on obtient 118 mg du dérivé 4(5)-dihydro corres pondant, fondant à 152-1530 C.
On peut rem placer le noir de palladium par un catalyseur constitué par 2 % de palladium sur du carbo- nate de strontium. b) On ajoute en l'espace de cinq minutes une solution de 143,2 mg du composé hydro géné ainsi obtenu dans 10 cc d'éther anhydre à une solution agitée d'hydrure de lithium et d'aluminium dans 15 cc d'éther et on agite le mélange pendant 45 minutes à 300 C. On ajoute de l'acétate d'éthyle jusqu'à cessation de la réaction énergique qui se produit.
On ajoute alors une solution saturée de sulfate de sodium jusqu'à ce que la matière floculée se dépose en formant un goudron visqueux. On décante la couche éthérée et on lave le goudron résiduel à plusieurs reprises au moyen d'éther. On lave la phase éthérée à l'eau jus qu'à neutralité des eaux de lavage, chacune des phases aqueuses étant à son tour lavée à l'éther, puis on mélange les extraits éthérés et on les sèche sur du sulfate de sodium anhydre. L'évaporation de l'éther donne 150 mg d'un produit cristallisé qui, après recristalli- sation au sein d'éther isopropylique, fond à 172-174 C.
Il s'agit du dérivé 3 a-hydroxy correspondant.
c) On refroidit à 0- C une solution de 325,5 mg du dérivé 3 a-hydroxy ainsi obtenu dans 20 cc de dioxane, on ajoute une solution de 450 mg d'acide périodique dihydraté dans 5 cc et on maintient le mélange à 5o C sous une atmosphère d'azote pendant 20 heures. On épuise la solution au moyen d'éther et on lave la phase éthérée au moyen d'une solution aqueuse à 10 % de bicarbonate de sodium, puis à l'eau.
On épuise les solutions aqueuses à l'éther et on mélange les extraits avec l'extrait éthéré principal. On chasse l'éther par éva poration et on sèche dans un exsiccateur sous vide la matière goudronneuse résultante contenant la dialdéhyde qui constitue le pro duit de départ du procédé selon l'invention ; ce produit n'a pas pu être obtenu sous la forme cristallisée. On dissout la dialdéhyde de départ ainsi préparée dans 30 cc de benzène anhydre, on ajoute un mélange de 4 gouttes d'acide acétique glacial, 3 gouttes de pipéridine et 2 g de sulfate de sodium anhydre et on maintient le mélange à 500 C pendant trois heures sous une atmo sphère d'azote.
La cyclisation a lieu également si l'on chauffe à des températures plus basses, mais elle s'effectue alors plus lentement. On ajoute de l'éther et on lave successivement la solution ainsi obtenue au moyen d'acide chlor hydrique aqueux,<I>N/10,</I> de carbonate de sodium aqueux à 10 0/0, puis à l'eau. On sèche la solu tion éthérée et on chasse l'éther par évapo ration, ce qui donne un produit cristallisé qui, par recristallisation au sein d'éther de pétrole en mélange avec de l'éther, donne 202 mg de l'aldéhyde désiré, dont le point de fusion est de 182-1840 C. Il s'agit du 3 a-hydroxy-17- formyl-A9c11>,1o-étiocholadiène.
Process for the preparation of a steroid bearing in position 17 an aldehyde function Swiss patent No 298506 describes a process for the preparation of O9 (II), is-bisdehydro-21-norprogesterone of formula
EMI0001.0005
from a compound of formula
EMI0001.0006
The present invention relates to a process for preparing a steroid bearing in position 17 an aldehyde function;
this process is characterized in that a solution of a compound of formula
EMI0001.0009
in an aromatic organic solvent, in the presence of a carboxylic acid salt of a nitrogenous organic base and in that the steroid thus formed is collected, of formula
EMI0001.0011
This steroid is useful as an interesting intermediate in the synthesis of progesterone. The following example illustrates the invention.
The starting product is prepared as follows, in three stages a) A suspension of 23 mg of palladium black in 20 cc of absolute methanol is made alkaline by adding two drops of a 10% aqueous solution of sodium hydroxide, 133.4 mg of the acetone ketal of 3-keto-16,17-dihydroxy-A4,9 (ii) are added
-D- homo-androstadiene [prepared as described in Patent No. 319580] and the mixture is shaken under a hydrogen atmosphere until absorption of hydrogen ceases. Celite brand product is added as a filter aid, the solution is filtered and the filtrate is evaporated to dryness. The product is chromatographed on 5 g of neutral alumina and the benzene eluate is subjected to fractional recrystallization from isopropyl ether: 118 mg of the corresponding 4 (5) -dihydro derivative is obtained, melting at 152-1530 C. .
The palladium black can be replaced by a catalyst consisting of 2% palladium on strontium carbonate. b) A solution of 143.2 mg of the hydrogenated compound thus obtained in 10 cc of anhydrous ether is added over the course of five minutes to a stirred solution of lithium aluminum hydride in 15 cc of ether and the mixture is stirred for 45 minutes at 300 ° C. Ethyl acetate is added until the vigorous reaction which occurs has ceased.
A saturated solution of sodium sulfate is then added until the flocculated material settles, forming a viscous tar. The ethereal layer is decanted and the residual tar is washed several times with ether. The ethereal phase is washed with water until the washings are neutral, each of the aqueous phases being in turn washed with ether, then the ethereal extracts are mixed and dried over anhydrous sodium sulfate. Evaporation of the ether gives 150 mg of a crystalline product which, after recrystallization from isopropyl ether, melts at 172-174 ° C.
This is the corresponding 3α-hydroxy derivative.
c) A solution of 325.5 mg of the 3 a-hydroxy derivative thus obtained in 20 cc of dioxane is cooled to 0 ° C., a solution of 450 mg of periodic acid dihydrate in 5 cc is added and the mixture is maintained at 5o C under a nitrogen atmosphere for 20 hours. The solution is depleted with ether and the ethereal phase is washed with 10% aqueous sodium bicarbonate solution, then with water.
The aqueous solutions are depleted with ether and the extracts are mixed with the main ethereal extract. The ether is removed by evaporation and the resulting tarry material containing the dialdehyde which constitutes the starting product of the process according to the invention is dried in a vacuum desiccator; this product could not be obtained in crystalline form. The starting dialdehyde thus prepared is dissolved in 30 cc of anhydrous benzene, a mixture of 4 drops of glacial acetic acid, 3 drops of piperidine and 2 g of anhydrous sodium sulfate is added and the mixture is maintained at 500 C for three hours under a nitrogen atmosphere.
Cyclization also takes place when heating to lower temperatures, but then proceeds more slowly. Ether is added and the solution thus obtained is washed successively with aqueous hydrochloric acid, <I> N / 10, </I> aqueous sodium carbonate at 10%, then with water. . The ethereal solution is dried and the ether is removed by evaporation, which gives a crystalline product which, on recrystallization from petroleum ether mixed with ether, gives 202 mg of the desired aldehyde, whose melting point is 182-1840 C. It is 3 a-hydroxy-17-formyl-A9c11>, 1o-etiocholadiene.
Claims (1)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US323174XA | 1953-05-19 | 1953-05-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CH323174A true CH323174A (en) | 1957-07-15 |
Family
ID=21864289
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CH323174D CH323174A (en) | 1953-05-19 | 1954-03-03 | Process for preparing a steroid carrying an aldehyde function in position 17 |
Country Status (1)
| Country | Link |
|---|---|
| CH (1) | CH323174A (en) |
-
1954
- 1954-03-03 CH CH323174D patent/CH323174A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2489232A (en) | Synthesis of biotin | |
| SU447886A1 (en) | The method of obtaining protected 4,6-0-alkylidene - - -glucopyranose | |
| CH495981A (en) | 2-oxoindolines bactericides analgesics diuretics | |
| CH323174A (en) | Process for preparing a steroid carrying an aldehyde function in position 17 | |
| US2760966A (en) | Compounds for synthesizing steroids | |
| US2760975A (en) | Compounds for synthesizing steroids | |
| CH380134A (en) | Process for the preparation of novel phenothiazine derivatives | |
| US2750373A (en) | Aralkanoyl and aralkenoyl derivatives of podocarpic acid esters | |
| CH327513A (en) | Process for preparing a derivative of pregnane | |
| US2701250A (en) | Process of producing indole-3-acetic acids | |
| SU150791A1 (en) | Method for preparing phenothiazine derivatives | |
| US2971009A (en) | 3, 7-dioxygenated 3alpha-methyl-3-benz[e]indanecarboxylic acids and lactones | |
| FR2655343A1 (en) | PROCESS FOR PREPARING SYNERGISTINE | |
| KR800000861B1 (en) | Process for preparing substituted indanyl-5-carboxylic acid | |
| SU899573A1 (en) | Process for preparing racemic 3-methyl ester of 1,8,d-bis-homo-estradiol | |
| CH629826A5 (en) | Steroids, process for preparing them and their use in the synthesis of tritium-labelled steroids | |
| CH384573A (en) | Process for preparing a 19-nor-steroid | |
| CH288942A (en) | Process for preparing an aromatic acylamidodiol. | |
| FR2494696A1 (en) | NOVEL PROCESS FOR THE PREPARATION OF 3-AMINO STEROIDS AND THEIR SALTS | |
| CH286745A (en) | A process for preparing an aromatic diacylated hydroxy-amino-ketone. | |
| CH388975A (en) | Process for the preparation of a reserpine derivative | |
| CH439279A (en) | Process for the preparation of bis-hydroxymethylene-pregnane | |
| CH428765A (en) | Process for the preparation of polycyclic internal ketals | |
| CH302796A (en) | Process for preparing pseudo-1-p-nitrophenyl-2-acetamido-propanediol-1,3. | |
| BE531443A (en) |